Ganesh Venkataraman Kaundinya, Senior V.P, Research at MOMENTA PHARMACEUTICALS INC (MNTA), sold 1,050 shares at $10.20 ($11K) on 2016-05-19, disclosed to the SEC on 2016-05-23.
Scheduled sale ($11k) by Senior V.P, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.20 | 397 | $4K | 37.9% |
| 2 | $10.20 | 426 | $4K | 40.6% |
| 3 | $10.11 | 227 | $2K | 21.5% |
| Total | $10.18 avg | 1,050 | $11K | 100% |
| Filing → |
| MNTA | SELL | 2018-08-10 | $18K | — | Filing → |
| MNTA | SELL | 2018-05-23 | $9K | — | Filing → |
| MNTA | SELL | 2018-05-14 | $8K | — | Filing → |